AJANTPHARM
Ajanta Pharma Limited
Pharmaceuticals · ₹41,294 Cr market cap
A manufacturer of specialty pharmaceutical finished dosages, this company develops and markets formulations across therapeutic categories including ophthalmology, gastroenterology, and dermatology for domestic and international markets. With vertically integrated operations spanning development, manufacturing, and marketing, the company has established a significant presence in India's pharmaceutical sector through its robust distribution network and focus on quality production.
1
Tracked investors holding
5
Tracked moves
₹3,308
Share price
Latest activity
Recent moveDecreased
Ravi Agrawal, Trustee Ravi Agrawal Trust (Promoter) sold 34.5 lakh shares of Ajanta Pharma for ₹1040.93 crore at ₹3017.20 apiece in an open market transaction, decreasing their stake from 13.00% to 10.24%.
Top investors holding Ajanta Pharma Limited
1.77%